BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1308423)

  • 1. [Macroprolactinoma at 6 years of age: diagnostic difficulties].
    Oliveira Mda C; Abech DD; Barbosa-Coutinho LM; Ferreira NP
    Arq Neuropsiquiatr; 1992 Sep; 50(3):397-401. PubMed ID: 1308423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hyperprolactinemia unrelated to prolactinoma].
    Krysiak R; Okopień B
    Wiad Lek; 2014; 67(2 Pt 1):101-11. PubMed ID: 25764785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinemia in children: clinical features and long-term results.
    Catli G; Abaci A; Altincik A; Demir K; Can S; Buyukgebiz A; Bober E
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1123-8. PubMed ID: 23329759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactinomas.
    Glezer A; Bronstein MD
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):71-8. PubMed ID: 25732643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe hyperprolactinemia associated with internal carotid artery aneurysm: differential diagnosis between prolactinoma and hypothalamic-pituitary disconnection.
    Duarte FH; Machado MC; Lima JR; Salgado LR
    Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1189-93. PubMed ID: 19082309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Index of suspicion.
    Pediatr Rev; 2004 Feb; 25(2):68-73. PubMed ID: 14754929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hyperprolactinemia and prolactinomas].
    Croughs RJ; van 't Verlaat JW
    Ned Tijdschr Geneeskd; 1991 Nov; 135(47):2210-3. PubMed ID: 1956454
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reversible blindness caused by an invasive prolactinoma].
    Schöfl-Siegert B; Brabant G; von zur Mühlen A; Schöfl C
    Dtsch Med Wochenschr; 2001 May; 126(21):621-4. PubMed ID: 11413749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Some issues in the diagnosis and treatment of hyperprolactinemia].
    Jin ZM
    Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prolactinoma].
    Glezer A; Bronstein MD
    Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):118-23. PubMed ID: 24830588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Giant invasive pituitary prolactinoma with falsely low serum prolactin: the significance of 'hook effect'.
    Fleseriu M; Lee M; Pineyro MM; Skugor M; Reddy SK; Siraj ES; Hamrahian AH
    J Neurooncol; 2006 Aug; 79(1):41-3. PubMed ID: 16598425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic ketoacidosis as the first manifestation of a mixed growth hormone and prolactin-secreting tumor].
    Carrasco de la Fuente M; González-Albarrán O; Pérez López G; Cano Megías M
    Endocrinol Nutr; 2010 Dec; 57(10):507-9. PubMed ID: 20705526
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of overweight, hyperprolactinaemia and suspected Cushing's syndrome].
    Iwen A; Lehnert H
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1880-1. PubMed ID: 20842611
    [No Abstract]   [Full Text] [Related]  

  • 14. Into the void: a giant aneurysm mimicking a macroprolactinoma.
    Lamback EB; Gouveia HR; Bulzico DA
    Endocrine; 2017 Nov; 58(2):394-395. PubMed ID: 28889239
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hyperprolactinemia. II. Diagnosis and treatment].
    Widala E; Nowakowski G; Kochańska-Dziurowicz AA
    Przegl Lek; 1999; 56(12):807-11. PubMed ID: 10789194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary tumors. Current concepts in diagnosis and management.
    Aron DC; Tyrrell JB; Wilson CB
    West J Med; 1995 Apr; 162(4):340-52. PubMed ID: 7747500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nasopharyngeal presentation of pituitary tumors. Differential diagnosis and treatment.
    van der Lely AJ; Knegt PP; Stefanko SZ; Tanghe HL; Singh R; Lamberts SW
    J Clin Endocrinol Metab; 1992 Apr; 74(4):811-3. PubMed ID: 1548346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic criteria of small sellar lesions with hyperprolactinemia: Prolactinoma or else.
    Cho A; Vila G; Marik W; Klotz S; Wolfsberger S; Micko A
    Front Endocrinol (Lausanne); 2022; 13():901385. PubMed ID: 36147567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step development of a pituitary adenoma: from hyperprolactinemic syndrome to Cushing's disease.
    Gheri RG; Boddi W; Ammannati F; Olivotto J; Nozzoli C; Franchi A; Bordi L; Luisi ML; Mennonna P
    J Endocrinol Invest; 1997 Apr; 20(4):240-4. PubMed ID: 9211134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.
    Gsponer J; De Tribolet N; Déruaz JP; Janzer R; Uské A; Mirimanoff RO; Reymond MJ; Rey F; Temler E; Gaillard RC; Gomez F
    Medicine (Baltimore); 1999 Jul; 78(4):236-69. PubMed ID: 10424206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.